Monday, September 14, 2026

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Apple’s Find My Feature Under Fire: Is Korea Getting the Short End of the Stick?

A petition has emerged urging an investigation into the restricted availability of Apple's Find My service in South Korea.

China’s One China Principle Pressure: What It Means for Taiwan and Korea Relations Ahead of the U.S.-China Summit

China pressures South Korea on the One China Principle ahead of the U.S.-China summit, affecting private and local events.

Tag: teaching methods

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.